319 related articles for article (PubMed ID: 22904674)
1. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
Kikuchi M; Katoh H; Waraya M; Tanaka Y; Ishii S; Tanaka T; Nishizawa N; Yokoi K; Minatani N; Ema A; Kosaka Y; Tanino H; Yamashita K; Watanabe M
Cancer Lett; 2017 Jan; 384():70-78. PubMed ID: 27756570
[TBL] [Abstract][Full Text] [Related]
3. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Kokubo K; Kobayashi H; Kim MS; Sidransky D; Watanabe M
Oncogene; 2010 Jun; 29(22):3263-75. PubMed ID: 20228841
[TBL] [Abstract][Full Text] [Related]
4. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis.
Waraya M; Yamashita K; Katoh H; Ooki A; Kawamata H; Nishimiya H; Nakamura K; Ema A; Watanabe M
BMC Cancer; 2012 Sep; 12():397. PubMed ID: 22958219
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
6. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
7. Methylation of
Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression.
Peng H; Long F; Wu Z; Chu Y; Li J; Kuai R; Zhang J; Kang Z; Zhang X; Guan M
Biomed Res Int; 2013; 2013():181384. PubMed ID: 23509688
[TBL] [Abstract][Full Text] [Related]
9. The homeobox only protein homeobox (HOPX) and colorectal cancer.
Yamashita K; Katoh H; Watanabe M
Int J Mol Sci; 2013 Nov; 14(12):23231-43. PubMed ID: 24287901
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J
PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928
[TBL] [Abstract][Full Text] [Related]
11. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer.
Ooizumi Y; Katoh H; Yokota M; Watanabe M; Yamashita K
Oncotarget; 2019 Oct; 10(57):5906-5918. PubMed ID: 31666923
[TBL] [Abstract][Full Text] [Related]
13. HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma.
Ren X; Yang X; Cheng B; Chen X; Zhang T; He Q; Li B; Li Y; Tang X; Wen X; Zhong Q; Kang T; Zeng M; Liu N; Ma J
Nat Commun; 2017 Feb; 8():14053. PubMed ID: 28146149
[TBL] [Abstract][Full Text] [Related]
14. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
15. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
17. Differential Prognostic Relevance of Promoter DNA Methylation of
Tanaka Y; Kosaka Y; Waraya M; Yokota K; Harada H; Kaida T; Kikuchi M; Minatani N; Nishimiya H; Katoh H; Sengoku N; Watanabe M; Yamashita K
Anticancer Res; 2019 May; 39(5):2289-2298. PubMed ID: 31092420
[TBL] [Abstract][Full Text] [Related]
18. HOPX functions as a tumour suppressor in head and neck cancer.
Yap LF; Lai SL; Patmanathan SN; Gokulan R; Robinson CM; White JB; Chai SJ; Rajadurai P; Prepageran N; Liew YT; Lopes V; Wei W; Hollows RJ; Murray PG; Lambert DW; Hunter KD; Paterson IC
Sci Rep; 2016 Dec; 6():38758. PubMed ID: 27934959
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1.
Zhang C; Wang L; Jin C; Zhou J; Peng C; Wang Y; Xu Z; Zhang D; Huang Y; Zhang Y; Ji D; Peng W; Jin K; Tang J; Feng Y; Sun Y
Cell Death Dis; 2021 Feb; 12(2):224. PubMed ID: 33637680
[TBL] [Abstract][Full Text] [Related]
20. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]